Brief: Shuttle Pharma To Enroll Patients In Phase 2 Clinical Trial Of Ropidoxuridine

Shuttle Pharmaceuticals Holdings

14/08/2024 21:12

Aug 14 (Reuters) - Shuttle Pharmaceuticals Holdings Inc
 SHPH.O :
    * SHUTTLE PHARMA READY TO ENROLL PATIENTS IN PHASE 2
CLINICAL
TRIAL OF ROPIDOXURIDINE FOR TREATMENT OF PATIENTS WITH
GLIOBLASTOMA

Source text for Eikon:  ID:nGNX5p9Grm 
Further company coverage:  SHPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))